Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Novel mutation in the NRLP3 manifesting as an intermediate phenotype of cryopyrinopathies

Rheumatology International(2020)10.1007/s00296-020-04683-5Source: DataRank Database

Novel mutation in the NRLP3 manifesting as an intermediate phenotype of cryopyrinopathies is a research paper published in Rheumatology International (2020). On theSindex it has a DataRank of 0. It has been cited 5 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

5 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (5 grants)Impact (FWCI 0.30)OA: closedTopics (39)IDs (PubMed, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (0/2)

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (7)

Amanda Virginia Cavalcante,Catherine Castro,Theresa Wampler Muskardin ORCID,João Bosco Oliveira ORCID,Timothy B. Niewold ORCID

Live enrichment

PubMed:32813153 OpenAlex:https://openalex.org/W3062132991

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior

Grant: 001

Conselho Nacional de Desenvolvimento Científico e Tecnológico

Grant: 2019/06632-5

National Institutes of Health

Grant: AR065964, DK107984

National Institutes of Health

Grant: 1R01DK107984-01A1

Novel Anti-Proteinuric Strategies Targeting Podocytes

National Institutes of Health

Grant: 5R01AR065964-05

Interferon Regulatory Factor 5 in Human Lupus Pathogenesis

FWCI

0.30

Citation Percentile

0.5%

Citation Trend

2021

2022

2025

closedLicense: Springer TDM

publisherhttps://link.springer.com/content/pdf/10.1007/s00296-020-04683-5.pdf

publisherhttps://link.springer.com/article/10.1007/s00296-020-04683-5/fulltext.html

journalhttps://doi.org/10.1007/s00296-020-04683-5

repositoryhttps://pubmed.ncbi.nlm.nih.gov/32813153

https://dx.doi.org/10.1007/s00296-020-04683-5

Fields of Study

Inflammasome and immune disordersGout, Hyperuricemia, Uric AcidAutoimmune and Inflammatory Disorders Research03 medical and health sciences0302 clinical medicine

MeSH Terms

NLR Family, Pyrin Domain-Containing 3 ProteinDiagnosis, DifferentialExonsHumansMaleMutationPhenotypeYoung AdultCryopyrin-Associated Periodic SyndromesAntibodies, Monoclonal, Humanized

Keywords

MedicineCanakinumabMissense mutationLivedo reticularisMEFVDermatologyGene mutationPopulationInternal medicineGastroenterologyMutationGeneticsAnakinraDiseaseGeneDiagnosis, DifferentialMaleYoung AdultPhenotypeNLR Family, Pyrin Domain-Containing 3 ProteinHumansExonsAntibodies, Monoclonal, HumanizedCryopyrin-Associated Periodic Syndromes

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Zero hunger

Novel mutation in the NRLP3 manifesting as an intermediate phenotype of cryopyrinopathies

FAIR Checklist

Authors (7)

Funding (5 grants)

Impact

Open Access

Topics